Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANJU VASUDEVAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1043203888
CMS profile
1601
Location
OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$8,827.27

216 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,403.15 208
Consulting Fee $4,095.00 2
Honoraria $200.00 1
Education $129.12 5

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $2,222.28 5
BeiGene USA, Inc. $2,007.96 4
Daiichi Sankyo Inc. $289.24 6
Novartis Pharmaceuticals Corporation $249.34 16
Janssen Biotech, Inc. $224.20 9
AstraZeneca Pharmaceuticals LP $216.66 10
Merck Sharp & Dohme LLC $205.81 9
Eisai Inc. $183.80 5
Regeneron Healthcare Solutions, Inc. $178.59 7
GENZYME CORPORATION $156.43 6
Incyte Corporation $141.84 6
Seagen Inc. $140.01 8
Amgen Inc. $133.36 8
Lilly USA, LLC $128.45 7
Alexion Pharmaceuticals, Inc. $127.00 5
Pharmacyclics LLC, An AbbVie Company $108.58 4
PFIZER INC. $107.68 6
Genentech USA, Inc. $107.16 7
Stemline Therapeutics Inc. $106.35 3
JAZZ PHARMACEUTICALS INC. $103.77 4
Mirati Therapeutics, Inc. $99.34 6
Genmab U.S., Inc. $93.52 1
Bayer Healthcare Pharmaceuticals Inc. $93.35 4
Myriad Genetic Laboratories, Inc. $78.76 2
Takeda Pharmaceuticals U.S.A., Inc. $78.27 3
Kite Pharma, Inc. $76.66 3
G1 Therapeutics, Inc. $75.56 4
Celgene Corporation $75.23 4
PharmaEssentia USA Corporation $73.01 4
SOBI, INC $71.24 4
Astellas Pharma US Inc $64.70 4
Gilead Sciences, Inc. $63.74 3
ARRAY BIOPHARMA INC $59.85 2
Puma Biotechnology, Inc. $49.86 3
EMD Serono, Inc. $47.14 3
Janssen Scientific Affairs, LLC $38.99 1
MorphoSys, US Inc. $38.43 2
Octapharma USA, Inc. $37.69 2
Immunocore Limited $36.18 1
Kyowa Kirin, Inc. $34.73 2
AbbVie Inc. $34.05 2
E.R. Squibb & Sons, L.L.C. $34.02 2
CTI BioPharma Corp. $31.68 2
SERVIER PHARMACEUTICALS LLC $29.02 2
Apellis Pharmaceuticals, Inc. $28.11 1
Rigel Pharmaceuticals, Inc. $26.26 2
CSL Behring $25.37 1
TerSera Therapeutics LLC $23.70 1
Exelixis Inc. $20.53 1
Amneal Pharmaceuticals LLC $20.10 1
ADC Therapeutics America, Inc. $19.19 1
Agios Pharmaceuticals, Inc. $18.57 1
AVEO Pharmaceuticals, Inc. $18.31 1
Secura Bio, Inc. $15.79 1
Verity Pharmaceuticals Inc. $15.27 1
Adaptive Biotechnologies Corporation $14.43 1
TAIHO ONCOLOGY, INC. $14.40 1
Heron Therapeutics, Inc. $13.71 1

Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANJU VASUDEVAN

NPI 1043203888 · CMS profile ID 1601

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

OCALA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1043203888?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1043203888?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1043203888?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ANJU VASUDEVAN, NPI 1043203888, CMS profile ID 1601, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 216 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1043203888?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

216 matching records · $8,827.27 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 216 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 216.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $17.0309/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993334053 CMS
Genentech USA, Inc. $14.9609/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040299884 CMS
PharmaEssentia USA Corporation $13.4309/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059316223 CMS
Regeneron Healthcare Solutions, Inc. $24.8309/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999511371 CMS
Seagen Inc. $16.2409/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995692957 CMS
Seagen Inc. $9.7609/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995692963 CMS
AstraZeneca Pharmaceuticals LP $17.2009/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012095937 CMS
Secura Bio, Inc. $15.7909/18/2023 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 1053101945 CMS
Amgen Inc. $12.8009/14/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020816377 CMS
Incyte Corporation $20.6109/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044371483 CMS
GlaxoSmithKline, LLC. $21.8009/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001899763 CMS
Stemline Therapeutics Inc. $66.5009/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040020977 CMS
CTI BioPharma Corp. $14.1309/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039687991 CMS
Amgen Inc. $18.4009/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020535645 CMS
PFIZER INC. $16.6209/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050104989 CMS
Daiichi Sankyo Inc. $11.4809/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006485833 CMS
Alexion Pharmaceuticals, Inc. $20.8108/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016997309 CMS
SOBI, INC $14.3608/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038132475 CMS
Alexion Pharmaceuticals, Inc. $1.0508/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016988033 CMS
Mirati Therapeutics, Inc. $15.0408/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058005637 CMS
Pharmacyclics LLC, An AbbVie Company $29.7408/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998297209 CMS
GENZYME CORPORATION $19.1608/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049725707 CMS
BeiGene USA, Inc. $10.4108/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051177111 CMS
BeiGene USA, Inc. $9.4408/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051177117 CMS
Astellas Pharma US Inc $15.8608/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034430175 CMS
Merck Sharp & Dohme LLC $25.7408/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048846479 CMS
Novartis Pharmaceuticals Corporation $15.0608/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993334043 CMS
Kite Pharma, Inc. $33.4308/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025274505 CMS
PharmaEssentia USA Corporation $22.0808/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059316171 CMS
Genentech USA, Inc. $13.7308/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040299909 CMS
GlaxoSmithKline, LLC. $16.2708/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001897717 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.0108/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055650552 CMS
Janssen Biotech, Inc. $25.0208/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988098143 CMS
Regeneron Healthcare Solutions, Inc. $20.3808/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999511363 CMS
Lilly USA, LLC $19.2208/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031261867 CMS
Lilly USA, LLC $20.1608/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031261865 CMS
Novartis Pharmaceuticals Corporation $24.1508/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993334039 CMS
AstraZeneca Pharmaceuticals LP $22.8208/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014849845 CMS
JAZZ PHARMACEUTICALS INC. $32.8508/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058409639 CMS
Celgene Corporation $18.6808/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016336525 CMS
Seagen Inc. $16.3708/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995692887 CMS
Janssen Biotech, Inc. $29.8007/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988098153 CMS
Incyte Corporation $26.0007/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044371187 CMS
Lilly USA, LLC $24.9007/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031240835 CMS
Lilly USA, LLC $0.1407/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031261863 CMS
Celgene Corporation $17.5507/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016336497 CMS
Genentech USA, Inc. $13.7907/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040299919 CMS
G1 Therapeutics, Inc. $17.7007/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059917469 CMS
SERVIER PHARMACEUTICALS LLC $14.7407/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055085031 CMS
Daiichi Sankyo Inc. $18.6907/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006417105 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $7,334.59 196
PY2020 $11,730.82 169
PY2021 $8,641.90 207
PY2022 $11,709.39 234
PY2023 $8,827.27 216
PY2024 $5,563.29 224
PY2025 $10,729.10 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $615,355.98 6
PY2024 Principal investigator $65,007.80 9
PY2023 Principal investigator $101,468.00 33
PY2022 Principal investigator $71,026.00 44
PY2021 Principal investigator $9,181.40 5
PY2020 Recipient $139.20 1
PY2020 Principal investigator $24,956.00 4
PY2019 Recipient $1,925.67 2
PY2019 Principal investigator $36,438.65 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $80.86 11/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312333
Principal investigator 1 Novartis Pharmaceuticals Corporation $121,062.48 09/04/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312335
Principal investigator 1 ABBVIE INC. $40,884.36 05/14/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484835
Principal investigator 1 ABBVIE INC. $9,045.00 05/13/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202484735
Principal investigator 1 ABBVIE INC. $5,000.00 05/07/2025 Non-covered Recipient Entity
OCALA ONCOLOGY CENTER PL
A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Subjects with High-Risk Diffuse Large B-Cell Lymphoma No dispute reported 06/30/2026 1202483379
Principal investigator 1 Novartis Pharmaceuticals Corporation $439,283.28 04/16/2025 Non-covered Recipient Entity
THE ONCOLOGY RESEARCH INSTITUTE LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190312337

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2022 Amount invested $0.00 1
PY2022 Value of interest $119,000.00 1
PY2021 Amount invested $0.00 1
PY2021 Value of interest $92,200.00 1
PY2020 Amount invested $0.00 1
PY2020 Value of interest $90,000.00 1
PY2019 Amount invested $0.00 1
PY2019 Value of interest $135,000.00 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

4 records · PY2019–2022

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2022 Innovation Technologies Inc $0.00 $119,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 954225435
PY2021 Innovation Technologies Inc $0.00 $92,200.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 849647691
PY2020 Innovation Technologies Inc $0.00 $90,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 749849307
PY2019 Innovation Technologies Inc $0.00 $135,000.00 Common Shares Physician Covered Recipient No dispute reported 06/30/2026 694466579